A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT06465329 · RECRUITING
Trial details
- NCT number
- NCT06465329
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2027-05-20
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.